866-997-4948(US-Canada Toll Free)

United States Diabetes Drug Market Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 106 Pages

In this report, the United States Diabetes Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Diabetes Drug in these regions, from 2013 to 2025 (forecast).

United States Diabetes Drug market competition by top manufacturers/players, with Diabetes Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Eli Lilly
Novo Nordisk
Abbott
AstraZeneca
Biocon
Sunpharma
Sanofi
Novartis
Merck
Pfizer
Daiichi Sankyo
Boehringer Ingelheim
Akros Pharma
Amgen
Adocia
Peptron
Takeda

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Insulin
Sensitizers
SGLT-2 Inhibitors
Alpha-glucosidase Inhibitors
Secretagogues
Peptide Analogs
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic
Others

Table of Contents

United States Diabetes Drug Market Report 2018
1 Diabetes Drug Overview
1.1 Product Overview and Scope of Diabetes Drug
1.2 Classification of Diabetes Drug by Product Category
1.2.1 United States Diabetes Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Diabetes Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Insulin
1.2.4 Sensitizers
1.2.5 SGLT-2 Inhibitors
1.2.6 Alpha-glucosidase Inhibitors
1.2.7 Secretagogues
1.2.8 Peptide Analogs
1.2.9 Others
1.3 United States Diabetes Drug Market by Application/End Users
1.3.1 United States Diabetes Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 United States Diabetes Drug Market by Region
1.4.1 United States Diabetes Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Diabetes Drug Status and Prospect (2013-2025)
1.4.3 Southwest Diabetes Drug Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Diabetes Drug Status and Prospect (2013-2025)
1.4.5 New England Diabetes Drug Status and Prospect (2013-2025)
1.4.6 The South Diabetes Drug Status and Prospect (2013-2025)
1.4.7 The Midwest Diabetes Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Diabetes Drug (2013-2025)
1.5.1 United States Diabetes Drug Sales and Growth Rate (2013-2025)
1.5.2 United States Diabetes Drug Revenue and Growth Rate (2013-2025)

2 United States Diabetes Drug Market Competition by Players/Suppliers
2.1 United States Diabetes Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Diabetes Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Diabetes Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Diabetes Drug Market Competitive Situation and Trends
2.4.1 United States Diabetes Drug Market Concentration Rate
2.4.2 United States Diabetes Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Diabetes Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Diabetes Drug Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Diabetes Drug Sales and Market Share by Region (2013-2018)
3.2 United States Diabetes Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Diabetes Drug Price by Region (2013-2018)

4 United States Diabetes Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Diabetes Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Diabetes Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Diabetes Drug Price by Type (2013-2018)
4.4 United States Diabetes Drug Sales Growth Rate by Type (2013-2018)

5 United States Diabetes Drug Sales (Volume) by Application (2013-2018)
5.1 United States Diabetes Drug Sales and Market Share by Application (2013-2018)
5.2 United States Diabetes Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Diabetes Drug Players/Suppliers Profiles and Sales Data
6.1 Eli Lilly
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Diabetes Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Eli Lilly Diabetes Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Novo Nordisk
6.2.2 Diabetes Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novo Nordisk Diabetes Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Abbott
6.3.2 Diabetes Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Abbott Diabetes Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 AstraZeneca
6.4.2 Diabetes Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 AstraZeneca Diabetes Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Biocon
6.5.2 Diabetes Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Biocon Diabetes Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Sunpharma
6.6.2 Diabetes Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sunpharma Diabetes Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Sanofi
6.7.2 Diabetes Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Sanofi Diabetes Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Novartis
6.8.2 Diabetes Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Novartis Diabetes Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Merck
6.9.2 Diabetes Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck Diabetes Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Pfizer
6.10.2 Diabetes Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Pfizer Diabetes Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Daiichi Sankyo
6.12 Boehringer Ingelheim
6.13 Akros Pharma
6.14 Amgen
6.15 Adocia
6.16 Peptron
6.17 Takeda

7 Diabetes Drug Manufacturing Cost Analysis
7.1 Diabetes Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Diabetes Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Diabetes Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Diabetes Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Diabetes Drug Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Diabetes Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Diabetes Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Diabetes Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Diabetes Drug Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Diabetes Drug
Figure United States Diabetes Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Diabetes Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Insulin Product Picture
Figure Sensitizers Product Picture
Figure SGLT-2 Inhibitors Product Picture
Figure Alpha-glucosidase Inhibitors Product Picture
Figure Secretagogues Product Picture
Figure Peptide Analogs Product Picture
Figure Others Product Picture
Figure United States Diabetes Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Diabetes Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Diabetes Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Diabetes Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Diabetes Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Diabetes Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Diabetes Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Diabetes Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Diabetes Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Diabetes Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Diabetes Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Diabetes Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Diabetes Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Diabetes Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Diabetes Drug Sales Share by Players/Suppliers
Figure 2017 United States Diabetes Drug Sales Share by Players/Suppliers
Figure United States Diabetes Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Diabetes Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Diabetes Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Diabetes Drug Revenue Share by Players/Suppliers
Figure 2017 United States Diabetes Drug Revenue Share by Players/Suppliers
Table United States Market Diabetes Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Diabetes Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Diabetes Drug Market Share of Top 3 Players/Suppliers
Figure United States Diabetes Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Diabetes Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Diabetes Drug Product Category
Table United States Diabetes Drug Sales (K Pcs) by Region (2013-2018)
Table United States Diabetes Drug Sales Share by Region (2013-2018)
Figure United States Diabetes Drug Sales Share by Region (2013-2018)
Figure United States Diabetes Drug Sales Market Share by Region in 2017
Table United States Diabetes Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Diabetes Drug Revenue Share by Region (2013-2018)
Figure United States Diabetes Drug Revenue Market Share by Region (2013-2018)
Figure United States Diabetes Drug Revenue Market Share by Region in 2017
Table United States Diabetes Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Diabetes Drug Sales (K Pcs) by Type (2013-2018)
Table United States Diabetes Drug Sales Share by Type (2013-2018)
Figure United States Diabetes Drug Sales Share by Type (2013-2018)
Figure United States Diabetes Drug Sales Market Share by Type in 2017
Table United States Diabetes Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Diabetes Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Diabetes Drug by Type (2013-2018)
Figure Revenue Market Share of Diabetes Drug by Type in 2017
Table United States Diabetes Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Diabetes Drug Sales Growth Rate by Type (2013-2018)
Table United States Diabetes Drug Sales (K Pcs) by Application (2013-2018)
Table United States Diabetes Drug Sales Market Share by Application (2013-2018)
Figure United States Diabetes Drug Sales Market Share by Application (2013-2018)
Figure United States Diabetes Drug Sales Market Share by Application in 2017
Table United States Diabetes Drug Sales Growth Rate by Application (2013-2018)
Figure United States Diabetes Drug Sales Growth Rate by Application (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Diabetes Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly Diabetes Drug Sales Growth Rate (2013-2018)
Figure Eli Lilly Diabetes Drug Sales Market Share in United States (2013-2018)
Figure Eli Lilly Diabetes Drug Revenue Market Share in United States (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Diabetes Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novo Nordisk Diabetes Drug Sales Growth Rate (2013-2018)
Figure Novo Nordisk Diabetes Drug Sales Market Share in United States (2013-2018)
Figure Novo Nordisk Diabetes Drug Revenue Market Share in United States (2013-2018)
Table Abbott Basic Information List
Table Abbott Diabetes Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Abbott Diabetes Drug Sales Growth Rate (2013-2018)
Figure Abbott Diabetes Drug Sales Market Share in United States (2013-2018)
Figure Abbott Diabetes Drug Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Diabetes Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Diabetes Drug Sales Growth Rate (2013-2018)
Figure AstraZeneca Diabetes Drug Sales Market Share in United States (2013-2018)
Figure AstraZeneca Diabetes Drug Revenue Market Share in United States (2013-2018)
Table Biocon Basic Information List
Table Biocon Diabetes Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biocon Diabetes Drug Sales Growth Rate (2013-2018)
Figure Biocon Diabetes Drug Sales Market Share in United States (2013-2018)
Figure Biocon Diabetes Drug Revenue Market Share in United States (2013-2018)
Table Sunpharma Basic Information List
Table Sunpharma Diabetes Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sunpharma Diabetes Drug Sales Growth Rate (2013-2018)
Figure Sunpharma Diabetes Drug Sales Market Share in United States (2013-2018)
Figure Sunpharma Diabetes Drug Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Diabetes Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sanofi Diabetes Drug Sales Growth Rate (2013-2018)
Figure Sanofi Diabetes Drug Sales Market Share in United States (2013-2018)
Figure Sanofi Diabetes Drug Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Diabetes Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Diabetes Drug Sales Growth Rate (2013-2018)
Figure Novartis Diabetes Drug Sales Market Share in United States (2013-2018)
Figure Novartis Diabetes Drug Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Diabetes Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck Diabetes Drug Sales Growth Rate (2013-2018)
Figure Merck Diabetes Drug Sales Market Share in United States (2013-2018)
Figure Merck Diabetes Drug Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Diabetes Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Diabetes Drug Sales Growth Rate (2013-2018)
Figure Pfizer Diabetes Drug Sales Market Share in United States (2013-2018)
Figure Pfizer Diabetes Drug Revenue Market Share in United States (2013-2018)
Table Daiichi Sankyo Basic Information List
Table Boehringer Ingelheim Basic Information List
Table Akros Pharma Basic Information List
Table Amgen Basic Information List
Table Adocia Basic Information List
Table Peptron Basic Information List
Table Takeda Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetes Drug
Figure Manufacturing Process Analysis of Diabetes Drug
Figure Diabetes Drug Industrial Chain Analysis
Table Raw Materials Sources of Diabetes Drug Major Players/Suppliers in 2017
Table Major Buyers of Diabetes Drug
Table Distributors/Traders List
Figure United States Diabetes Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Diabetes Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Diabetes Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Diabetes Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Diabetes Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Diabetes Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Diabetes Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Diabetes Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Diabetes Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Diabetes Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Diabetes Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Diabetes Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Diabetes Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *